NL-OMON21916RecruitingNot Applicable
ongitudinal prediction of progression in MS: 'The Amsterdam MS Cohort'
VU University Medical Center0 sites260 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 260
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational non invasive
Eligibility Criteria
Inclusion Criteria
- •All people with MS and all healthy controls who have previously participated in the Presto (local ethics committee number: 2002/140), GeneOCT (2004/9), or LTD (2010/336) studies (collectively also known as the Amsterdam MS Cohort”) and have not provided objection to be contacted for follow-up study, or have been enquired to join the cohort based on the Amsterdam MS Cohort (2020/269) protocol.
Exclusion Criteria
- •MS patients unable to undergo the minimal data collection (as described in Methods section) or comorbidity that interferes with participation in this study (controls).
Investigators
Similar Trials
Recruiting
Not Applicable
ongitudinal prediction of progression in MS: The PrograMS CohortMSDisseminated sclerosis10012303NL-OMON51918Vrije Universiteit Medisch Centrum300
Active, not recruiting
Unknown
Identifying genetic determinants of outcome in multiple sclerosisNervous System DiseasesMultiple sclerosisISRCTN41688895Cambridge University Hospitals NHS Foundation Trust10,000
Completed
Not Applicable
Predictive markers for progessive disease progression in Acne Inversa (AI)/Hidradentitis Suppurativa (HS) patientsACNEINVERSAL73L73.2Other follicular disordersHidradenitis suppurativaDRKS00013778AbbVie Deutschland GmbH Co. KG481
Completed
Not Applicable
Does MS grey matter atrophy progress faster in regions with more damage in connected white matter?10012303multiple sclerosisNL-OMON43307Vrije Universiteit Medisch Centrum55
Completed
Not Applicable
Artificial Intelligence in Predicting Progression in Multiple Sclerosis StudyMultiple Sclerosis LesionMultiple Sclerosis Brain LesionMultiple SclerosisNCT05426980University of Ljubljana654